Payor Mix definition

Payor Mix means the percentage of occupied beds for which reimbursement is or was paid for by a source other than a Medicaid program as compared to the total number of occupied beds.

Examples of Payor Mix in a sentence

  • Medicare Advantage products, as they are administered via commercial insurers, are includedwithin the “Other” category.” 11 [source: DaVita Application, p20; DaVita January 31, 2019 Screening Responses pdf, p4] Table 4DaVita Silverdale Payor Mix Using the assumptions stated above, DaVita’s projected the end-of-year number of in-center and dialyses and patients for the 9-station DaVita Silverdale in years 2021 through 2024 are shown below.

  • The anticipated Payor Mix is 62.5% Commercial and 37.5% Medicare with an estimated reimbursement at $2,400 per day.

  • Payor mix was as follows on June 30: Payor Mix Note 6 Contract Assets In compliance with ASC 606, estimated reimbursement from patients that were inhouse at the end of the reporting period are reported as Contract Assets on the statements of financial position.

  • Payor Mix (Use previous fiscal year for all patient data; Use Trauma Registry Verification Report for Trauma Patient Information) PayerAll Patients (%)Trauma Patients (%)Commercial Medicare Medicaid HMO/PPO Workman’s Compensation Uncompensated/Indigent Other/Not Specified D.

  • Payor Mix Patient paid 10%, Medicare 31%, Medicaid 36%, Commercial 23%.

  • Total Daily Cost of Treatment Percent Savings with Home Care Home Care 73 Outpatient 126 0.42 SNF 240 0.7 Hospital 1263 0.94 Note: 1 Per company estimates Attractive Payor Mix Consolidated Payor Mix Home Infusion Payor Mix Managed Care 0.51 Medicare 0.29 Medicaid 0.2 Managed Care 0.72 Medicare 0.17 Medicaid 0.11 Healthcare Acquisition Corp.

  • Projected Payor Mix OY2 1/1/2021 - 12/31/2021As a Percent of Total Payor SourceSource: Application page 72 As shown in the table above, during the second full calendar year of operation, the applicant projects that 1% of the dialysis patients will be private pay patients and 82% will have all or part of their services paid for by Medicare and/or Medicaid.

  • Census and Payor Mix Reports........................................

  • Payor Mix Change General Federal Other Total FTEAgency Request($514,819)($772,229)$1,287,048$00.00Governor's Recommendation($514,819)($772,229)$1,287,048$00.00 The agency requests a decrease of ($514,819) in general funds, a decrease of ($772,229) in federal funds and an increase of $1,287,048 in other fund expenditure authority for a change in the payor mix.

  • Carolinas Medical Center (MRI Services) Projected Payor Mix, CY 2030Payor CategoryMRI Services as Percent of TotalSelf-Pay7.7%Medicare*31.5%Medicaid*20.1%Insurance*37.5%Other**3.2%Total100.0%*Including any managed care plans**Including Workers Compensation and TRICARE^CMHA internal data does not include charity care as a payor source for patients.

Related to Payor Mix

  • Third Party Royalties means royalties or payments actually paid by the Company or its Affiliates to an unaffiliated third party for the right to use or exploit technology, products or proprietary rights of such third party to create or sell Licensed Product/s, which third party’s rights would otherwise be infringed or violated.

  • Third Party Payment means payment through an instrument issued from a bank account other than that of the beneficiary investor. In case of payments from a joint bank account, the first named investor/holder of the mutual fund folio has to be one of the joint holders of the bank account from which payment is made.

  • Payors shall have the meaning set forth in Section 3.27.

  • Third Party Payments means the payment made through instruments issued from an account other than that of the beneficiary investor mentioned in the application form. However, in case of payments from a joint bank account, the first named applicant/investor has to be one of the joint holders of the bank account from which payment is made.

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound, and (b) has been placed on the market pursuant to a validly granted marketing authorization.

  • Royalty Product means, either (a) an Alnylam Royalty Product, or (b) an Inex Royalty Product.

  • Baseline Personnel Security Standard means the pre-employment controls for all civil servants, members of the Armed Forces, temporary staff and government contractors generally.

  • Fully Burdened Manufacturing Cost means, with respect to any Licensed Product supplied by or on behalf of NVCR to Zai hereunder if such Licensed Product (or any precursor or intermediate thereof) is manufactured by a Third Party manufacturer [***].

  • Approved Pricing Service means a pricing or quotation service as set forth in Schedule 1.01(a) or any other pricing or quotation service approved by the Board of Directors of the Borrower and designated in writing to the Administrative Agent (which designation shall be accompanied by a copy of a resolution of the Board of Directors of the Borrower that such pricing or quotation service has been approved by the Borrower).

  • Royalty-Bearing Product means (a) any Product that is not a Co-Developed Product and (b) any Co-Developed Product to the extent sold outside of the Co-Development Territory.

  • Third-party payer means an entity that is, by

  • Licensed Services means all functions performed by the Licensed System.

  • Royalty Rate means the percentage defined in Exhibit B.

  • Net Sales means [***].

  • Approved Product means any water fitting, plumbing product, material or component which is the subject of an existing WRAS Approval;

  • CREFC® Intellectual Property Royalty License Fee Rate With respect to each Mortgage Loan, a rate equal to 0.0005% per annum.

  • Licensed service area means the geographic area in which

  • Royalty Payment has the meaning set forth in Section 6.1.

  • Licensed Service means a service provided using Licensed Products or Licensed Methods, including, without limitation, any such service provided in the form of contract research or other research performed by Licensee on behalf of a third party.

  • Royalty Payments has the meaning set forth in Section 7.3.1.

  • Approved Price means the "fair value" as determined by the Trust in accordance with the valuation procedures adopted from time to time by the Board of Trustees of the Trust and for which the Trust receives a marked-to-market price (which, for the purpose of clarity, shall not mean Market Value) from an independent source at least semi-annually.

  • Volumetric Production Payments means production payment obligations recorded as deferred revenue in accordance with GAAP, together with all undertakings and obligations in connection therewith.

  • Bundled Product means Product sold together with any other product(s) or service(s) at a single unit price, whether packaged together or separately, and which other product(s) or service(s) have material independent value from Product itself.

  • Payor means a trustee, insurer, business entity, employer, government, governmental subdivision or agency, or other person authorized or obligated by law or a governing instrument to make payments.

  • Licensed System means, collectively:

  • Combination Product means any combination of the Product with one (1) or more other active ingredients, products or services that is not the Product, where such products are sold either as a fixed dose/unit or as separate doses/units in a single package for a single price.